Life Science Accounting Conferences (accounting for pharmaceutical companies)
Accounting Conferences and Seminars offered the Life Science Accounting Update in San Jose, CA and Parsippany, NJ in 2012.
In May, 2013 an updated conference will be held back at the Hyatt Santa Clara, CA. Here is a link to the agenda and details: https://acslive.com/events/lifescience_2013.html
The 2012 conferences led off with a technical accounting update led by KPMG where they discussed the AICPA IPR&D draft practice guide, intangibles, goodwill and testing indefinite-lived intangible assets for impairment, medical device excise tax and an SEC Update.
KPMG followed with a Tax Update covering global supply change, tax consideration related to accounting for share-based compensation under ASC 718, considerations for global equity plans and a Legislative Tax update.
A roundtable discussion led by conference chair and Deloitte partner, Brian Jobe, allowed all the attendees to introduce themselves and provide some background.
PwC led a session on Collaboration Agreement and Variable Interest Entities where the speakers discussed key considerations of the amended consolidation standard including red flags
Deloitte led the next session on Revenue from Contracts with Customers including a summary of the revenue recognition project to date and a summary of key provisions in the FASB exposure draft and potential industry implications.
Bill Greenrose, Deloitte Director, led the regulatory development discussion on the global regulatory framework, navigating compliance challenges, staying ahead of enforcement trends and competing in a changing regulatory environment.
The conference concluded with additional session on leasing, valuation and an industry overview by Citi, and a discussion of capital structures by Deloitte.